π Exciting times for #KZIA! Trading at $9.83, it's riding a bullish wave above its 10-day SMA & 20-day EMA. With positive MACD and RSI at 57, there's room to grow! π― Target: $10.50-$11.00. Volatility is high, so stay sharp! π #FeetrAI #StockMarket #InvestSmart
#KZIA Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities
www.stocktitan.net/news/KZIA/kazia-therapeu...
π Exciting times for #KZIA! With FDA approval boosting confidence, Kazia Therapeutics is on the rise. Bullish indicators and a strong MACD suggest upward momentum, but watch that RSI! Consider a long position at $10.50, targeting $11.50-$12.00. Stay sharp! π #Biotech
π Exciting times for #KZIA! Trading at $10.59, it's breaking barriers with bullish momentum and strong technicals. With targets at $11.50 & $12.50, and a stop loss at $9.80, this could be a thrilling ride! Keep an eye on those clinical trial updates! π #FeetrAI #Stocks
π Exciting times for #KZIA! Trading at $10.13, it's riding a bullish wave with strong upward momentum. With a 10-day SMA of $8.02 and positive MACD, the technicals are hot! Consider going long with targets at $11 & $12. Stay sharp for any market shifts! π #FeetrAI
π Exciting times for #KZIA! Trading at $10.13 with bullish momentum, the 10-day SMA at $8.02 & 8-day EMA at $9.01 signal potential gains. MACD is positive, RSI at 59βroom to grow! Consider a LONG position targeting $11-$12. Stay alert for market shifts! #FeetrAI #Stocks π
π Exciting times for #KZIA! Despite recent dips, bullish MACD and strong short-term moving averages hint at a potential rebound. π Consider going long at $10.00, targeting $11.00 & $12.00 with a stop at $9.50. Moderate confidence in hitting the first target! #Stocks #FeetrAI
π Exciting times for #KZIA! With a surge in volume and trading above key moving averages, bullish momentum is building. π RSI hints caution, but MACD supports upward potential. Consider entering at $10.00 with targets at $11.50 & $12.50. Stop loss: $9.50. #FeetrAI
π Exciting times for #KZIA! With a strong bullish momentum, it's trading at $11.33, well above its 10-day SMA of $8.16. Despite high RSI levels, the MACD supports further gains. Targeting $12.00 & $12.50 with a stop loss at $10.80. Stay alert for market shifts! π #FeetrAI
Most searched small-cap stocks, Wed Nov 19th - #LAC #KZIA #RXRX #QUBT #SGML #SGML #SEMR #EOSE #NUVB #OLMA #DNN #AGIO #PLUG #SGBX #ONDS #IQ #EVH #CEP #CAAS #BORR #AMLX - More: crystalequityresearch.com/most-searche... - #smallcap
#KZIA Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner
www.stocktitan.net/news/KZIA/kazia-therapeu...
#KZIA Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
www.stocktitan.net/news/KZIA/kazia-therapeu...
#KZIA Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy
www.stocktitan.net/news/KZIA/kazia-therapeu...
#KZIA Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market
www.stocktitan.net/news/KZIA/kazia-therapeu...
Breaking News: ( NASDAQ: #KZIA ) Kazia Therapeutics Reports Positive Initial Phase 1b Trial Data from First Triple-Negative Breast Cancer Patient Treated with Paxalisib Combination Regimen
πΊπ¦ #NowPlaying on BBC #Radio3's #RoundMidnight
Omar, K.ZIA & The Swag:
π΅ Won't Let You Down (feat. K.ZIA & The Swag)
#BBCRadio3 #Omar #KZIA #TheSwag
βΆοΈ πͺ Automagic π show π» playlist on Spotify
βΆοΈ Track on #Spotify:
π Exciting times for #KZIA! Riding a bullish wave with transformative preclinical data, but watch out for declining volume. Consider going long at $9.20, targeting $9.80 & $10.00. Tight risk management is key! π Stay alert for market shifts! #Biotech #Stocks #FeetrAI
π Exciting times for #KZIA! Bullish momentum fueled by positive trial results & FDA fast-track. Trading above EMA with a high RSIβwatch for a pullback. MACD supports upward trend. Entry: $9.20, Targets: $10 & $10.50, Stop: $8.80. Stay sharp, volatility ahead! π #FeetrAI
π Exciting times for #KZIA! After successful Phase 2 trials, it's soaring above key moving averages with strong momentum. Ideal entry at $9.20, targeting $9.50 & $9.80. But watch out for volatilityβset your stop loss at $8.90. π #FeetrAI #StockMarket #BiotechBoom
π Exciting times for #KZIA! Bullish momentum with strong buying interest driven by preclinical data. Trading above EMAs, but watch out for overbought signals. Entry at $9.20, targeting $9.60 & $10.00. Stop loss at $8.90. Stay alert for market shifts! π #FeetrAI
π Exciting times for #KZIA! Recent surges fueled by promising Paxalisib data. RSI > 80 signals overbought, but MACD shows bullish vibes. π Consider a long position at $9.40, targeting $10-$10.50. Caution: Volatility ahead! Stay sharp & manage risk! #FeetrAI #Stocks
π Exciting times for #KZIA! Bullish momentum fueled by positive trials & a big pharma partnership. RSI over 80, MACD hints at more gains. Consolidation at $9.4 with volume spikes suggests potential upside. Targets: $10.5 & $11.5. Stop loss: $8.5. Oncology growth ahead! π #FeetrAI
π Exciting times for #KZIA! Recent preclinical data on Paxalisib has stirred up volatility. With RSI high and MACD bullish, there's potential for upward movement. Consider entering at $9.30, targeting $10.00 & $10.50. Stop loss at $8.80. Stay sharp! π #FeetrAI
π Exciting times for #KZIA! Recent preclinical data for Paxalisib has sparked a price surge, but beware of overbought signals and speculative trading. Consider shorting at $9.70, targeting $9.00 & $8.50 with a stop at $10.20. Stay sharp, traders! #FeetrAI #StockMarket
Most searched small-cap stocks, Wed Jun 11th - #IREN #RXRX #APLD #KLTO #IOVA #RIG #KZIA #NUVB #XTIA #VTAK #JBLU #CLSK #SEDG #RMR #QUBT #HIVE #NNE #MGNX #LEU #ESPR - More: crystalequityresearch.com/SmCpStr/ - #smallcap
Breaking News: ( NASDAQ: #KZIA ) Kazia Surges 80% on Preclinical Data Showing Paxalisib May Reverse Immunotherapy Resistance in Breast Cancer
